The Alzheimer's Drug Discovery Foundation (ADDF) provides funding to academic centers and biotechs from around the world that are advancing therapeutic and biomarker development for Alzheimer's and related dementias. We have dedicated our funding to several key areas:
- Translational research to develop new drugs and build preclinical evidence
- IND-enabling studies and early-stage clinical trials for novel and repurposed drugs
- Development and validation of plasma, CSF, neuroimaging and digital biomarkers
- Epidemiological studies and comparative effectiveness research
Upcoming 2021 deadlines
Must be received by 5:00 pm ET on the deadline date.
- Letter of Intent: February 5, 2021
- Invited Full Proposal: April 16, 2021
For more information, visit the ADDF Funding Opportunities page
Contact Name:
oris@uleth.ca
Grant Amount:
Varies
Grant Location:
External
External Deadline:
Friday, February 5, 2021
Internal Deadline:
Friday, January 22, 2021
Grant Type:
Research
Grant Area:
Health
Natural Science
Other
Grant Eligibility:
Faculty
Postdoc
Other